جست‌وجوی استاد و پژوهشگر

• Radiation Therapy
• Clinical Trials
• Treatment Planning
• +۳ مورد دیگر

Chris Thomas is a researcher specializing in radiation therapy and medical imaging applications. His work focuses on advancing treatment planning techniques using artificial intelligence and improving outcomes through precision oncology. He has contributed to studies on immune response mechanisms in severe COVID-19 cases and post-pandemic respiratory recovery. His research bridges clinical practice and technological innovation in radiotherapy. Research interests include radiation dosimetry optimization, PET/MRI integration in treatment planning, and clinical trial methodologies for oncological interventions. Notably, his doctoral thesis developed deep learning approaches to reduce gastrointestinal toxicity in pelvic radiotherapy. Recent publications explore neural network-driven dose-prediction models, PET-guided radiotherapy protocols, and immune system aging's role in disease severity. Collaborations span oncology, radiology, and computational biology disciplines.

• Brachytherapy
• Image-Guided Radiation Therapy
• Radiation Oncology
• +۷ مورد دیگر

Role & Affiliations: Dae Yup Han is an Assistant Professor in the Department of Therapeutic Radiology at Yale School of Medicine and a faculty member of the Yale Medical Physics Residency Program. He is board-certified in Therapeutic Medical Physics by the American Board of Radiology (DABR), with expertise in advanced brachytherapy and image-guided radiation therapy. Education: Ph.D. in Electrical Engineering (University of California, San Diego) CAMPEP-accredited Medical Physics Certificate (University of California, Los Angeles) Medical Physics Residency (University of California, San Francisco) Research Interests: Translational implementation of advanced brachytherapy and image-guided radiation therapy Multi-modality image-guided target tracking systems for adaptive radiotherapy Intravascular brachytherapy treatment planning systems Novel brachytherapy applicators with directional dose modulation Integration of imaging, computation, and radiation delivery in radiation oncology Publications & Contributions: Dr. Han has authored numerous peer-reviewed articles focusing on brachytherapy techniques, dosimetric accuracy, and medical device innovation. His work emphasizes clinical translation of technologies like dynamic modulated brachytherapy (DMBT) and PET-guided radiation therapy. Collaborations: Active partnerships with academic, clinical, and industry collaborators to advance radiation oncology through engineering, physics, and medical innovation.

Omid Nohadaniمشاهده پروفایل

دانشیار

• Optimization
• Robust Optimization
• Operations Research
• +۵ مورد دیگر

Omid Nohadani is an Associate Professor at Northwestern University in the Department of Industrial Engineering and Management Sciences and holds a joint appointment in Radiation Oncology. He also serves as an Associate Professor in the Technological Institute. Previously, he was an Assistant Professor at Purdue University and held academic roles at Harvard Medical School and MIT. His research focuses on robust optimization techniques applied to healthcare systems, supply chain management, medical physics, and engineering design. He completed his Ph.D. in Physics at the University of Southern California and a postdoctoral fellowship in Operations Research at MIT. Education: Ph.D. in Physics, University of Southern California (2005) Postdoctoral Research, Operations Research Center, MIT (2006–2010) Diploma in Physics, University of Bonn, Germany (2000) Research Interests: Robust optimization methods, dynamic decision-making under uncertainty, applications in radiation therapy planning, medical supply chains, and high-performance computing. His work bridges theoretical optimization, computational methods, and real-world engineering challenges in healthcare and manufacturing. Advising & Grants: Supervises current PhD students including Kartikey Sharma and Nastaran Shojaei. Former advisees include Arka Roy (now Assistant Professor at UT San Antonio) and Andrew Zheng (PhD student at MIT). His grants and projects focus on optimizing treatment plans in radiation oncology and robust supply chain systems. Labs & Teams: Active in interdisciplinary teams at Northwestern’s Technological Institute and collaborates with medical institutions on healthcare optimization projects. His research group specializes in developing algorithms for medical physics and industrial engineering applications.

Xiangyang Meiمشاهده پروفایل

استادیار

• Advanced Radiation Therapy Techniques
• Medical Physics Education
• Quality Assurance in Radiation Oncology
• +۳ مورد دیگر

Dr. Xiangyang Mei is an Assistant Professor specializing in Radiation Oncology and Medical Physics. His clinical interests include advanced radiation therapy techniques such as Image Guided Radiation Therapy (IGRT), Intensity Modulated Radiation Therapy (IMRT), Volume Modulated Arc Therapy (VMAT), Stereotactic Ablative Radiation Therapy (SABR), High Dose Rate (HDR) Brachytherapy, and Orthovoltage X-Ray Radiation Therapy. He focuses on improving quality assurance processes for safe and accurate radiation delivery. In education, Dr. Mei emphasizes training medical physics and radiation oncology residents, as well as teaching undergraduate and graduate students in medical physics. His research explores novel HDR Brachytherapy methods and the implementation of advanced external beam radiation therapy techniques. He also investigates new quality assurance protocols and their impact on clinical outcomes. Dr. Mei’s academic contributions span remote sensing and geoinformatics, with publications addressing climate change, urbanization, and environmental monitoring using satellite data. His methodologies often integrate machine learning, deep learning, and spatial analysis to solve complex problems in health, ecology, and urban planning. His work demonstrates interdisciplinary collaboration across medical physics, environmental science, and data science, with a focus on advancing both clinical practices and geospatial technologies.

• Radiation Therapy
• Proton Therapy
• Intensity-Modulated Radiation Therapy (IMRT)
• +۷ مورد دیگر

Dr. Sebastiaan Breedveld is an Associate Professor in the Department of Radiotherapy at Erasmus MC, a leading medical institution in the Netherlands. His work bridges medical physics, radiation oncology, and artificial intelligence, with a strong focus on improving cancer treatment through advanced radiotherapy techniques. Research Interests: His primary research areas include proton therapy, intensity-modulated radiation therapy (IMRT), automated treatment planning, and the application of deep learning in dose prediction and plan optimization. He is particularly interested in making adaptive radiotherapy more efficient and clinically feasible, especially for complex cases such as head and neck and oropharyngeal cancers. The recent trend in his publications shows a strong shift toward automation and AI-driven solutions in radiotherapy, aiming to reduce planning time while maintaining high dosimetric quality. His work integrates machine learning models for instantaneous dose prediction, robustness evaluation, and beam angle optimization, significantly advancing the field of intelligent treatment planning. Supervision & Collaboration: He has supervised multiple academic projects, including doctoral theses, and collaborates extensively with researchers in medical physics and oncology. His network spans national and international institutions, focusing on innovation in clinical radiotherapy workflows. Laboratory & Team: While not explicitly mentioned, his involvement in projects like 'iCycle-pBAO' and deep learning dose prediction suggests he is part of or leads a research team focused on algorithm development and clinical translation within the Radiotherapy department at Erasmus MC.

• Radiation Oncology
• Magnetic Resonance Imaging
• Cervical Cancer
• +۳ مورد دیگر

Anouk Corbeau is a Researcher in the Radiotherapy department at Erasmus MC, Erasmus University Rotterdam, specializing in advanced imaging techniques and treatment optimization for cervical cancer radiotherapy. Her research focuses on Magnetic Resonance Imaging reproducibility , chemoradiation toxicity modeling , and proton therapy planning for gynecological malignancies. Key interests include water-fat MRI quantification, bone marrow radiation dosimetry, and robustness analysis of treatment margins using phantom and volunteer studies. Recent publications (2021-2024) demonstrate clinical translation of her work, with systematic reviews establishing dose-toxicity correlations in Radiation and Oncology (54 Scopus citations) and technical innovations in MRI reproducibility published in Physics and Imaging in Radiation Oncology . Her IMPT strategy research addresses critical gaps in cervical cancer proton therapy planning. Collaborations with S. C. Kuipers, J. Godart, and R. A. Nout highlight multidisciplinary teamwork across radiation physics, medical oncology, and clinical gynecology. Her work has influenced clinical guidelines and accumulated over 59 Mendeley readers, indicating significant field impact.

Weisi Yanمشاهده پروفایل

دانشیار

• Radiation Oncology
• Cancer Therapy
• Pharmacology
• +۷ مورد دیگر

Weisi Yan, MD, PhD, is an Associate Professor in the Department of Radiation Medicine at the University of Kentucky College of Medicine and a practicing radiation oncologist at the UK Markey Cancer Center in Lexington, KY. He specializes in treating a wide range of cancers, including lung, esophageal, blood cancers (leukemia, lymphoma, myeloma), head and neck, skin cancers, melanoma, bone cancer, and sarcomas. His clinical expertise includes External Beam Radiation and Intensity-Modulated Radiation Therapy (IMRT), with a strong focus on personalized treatment planning and patient education, particularly in the fabrication and use of radiation masks. Dr. Yan is board certified by the American Board of Radiology in Radiation Oncology. Education: MD, China Medical University, Taichung City, China PhD, Pharmacology, Weill Cornell Medicine, New York, NY His research interests bridge radiation oncology and pharmacology, particularly in optimizing cancer therapies through advanced radiation techniques and molecular understanding of tumor response. Although no recent publications are listed, his dual MD/PhD training suggests a strong foundation in translational research. Dr. Yan has received high patient satisfaction ratings, with a 4.71 out of 5 based on 8 reviews, reflecting his clear communication, thorough explanations, and empathetic care. One review noted his detailed guidance on treatment masks, while others emphasized trust and confidence in his clinical judgment. A minority review mentioned concerns about rushed interaction and prescription practices. He is actively involved in clinical care and academic medicine, contributing to the mission of the Markey Cancer Center. No information is available about formal mentorship of students or trainees, research grants, or scientific awards in the current text.

Karen Chengمشاهده پروفایل

استادیار

• Radiation Oncology
• Intensity Modulated Radiation Therapy
• Stereotactic Body Radiation Therapy
• +۱۶ مورد دیگر

Karen Cheng, M.D., is an Assistant Clinical Professor in the Department of Radiation Oncology at City of Hope, with clinical practice sites in Riverside and San Bernardino, California. She is actively involved in clinical care and academic medicine, specializing in advanced radiation therapies including intensity-modulated, stereotactic, and brachytherapy techniques for cancers of the breast, cervix, brain, head and neck, and prostate. Her educational background includes a Doctor of Medicine from Boston University School of Medicine (2015–2019) and a Bachelor of Science in Bioengineering from the University of California at Berkeley (2011–2015). She completed an internal medicine internship at North Shore University Hospital / LIJ Medical Center and a radiation oncology residency at USC/Los Angeles General Medical Center, where she served as chief resident. Dr. Cheng’s research spans radiation oncology innovation, radiomics, AI in imaging, and health equity. Her recent publications focus on technical advancements in brachytherapy, hippocampal-sparing techniques, radiomics datasets, and patient understanding of radiation therapy in diverse populations. This reflects a strong trend toward integrating technology with patient-centered care and addressing disparities in oncology. American College of Radiation Oncology Excellence in Mentorship Award Keck School of Medicine DEI Leaders Scholarship Boston University School of Medicine Anne and David Mischel Cancer Research Award MassChallenge Startup Accelerator Finalist Clinton Global Initiative University Innovation Fund Awardee Multiple grants and leadership awards in innovation, diversity, and research Dr. Cheng has been involved in numerous research projects and clinical initiatives, supported by grants from organizations such as the American Society of Clinical Oncology, Chinese American Medical Society, and Grand Challenges Canada. She has also participated in innovation competitions and hackathons, demonstrating a strong commitment to translational research and community impact. She is fluent in English, Mandarin, Taiwanese, and Spanish, enhancing her ability to serve diverse patient populations. She contributes to academic knowledge through a robust publication record and participation in developing clinical trials at City of Hope, a renowned institution for cancer care and research.

• Radiation Therapy
• Brachytherapy
• Medical Physics
• +۴ مورد دیگر

Åsa Carlsson Tedgren is a Researcher at the Department of Oncology-Pathology , Karolinska Institutet, and leads the Clinical Radiation Therapy research group. She is affiliated with the Karolinska University Hospital's radiotherapy department, collaborating with oncologists and physicists on brachytherapy , external beam radiation therapy , and dual-energy CT applications. Her work spans radiation dosimetry , treatment planning , and detector response analysis . She supervises numerous PhD students, including Freja Alpsten Simon Dahlander Elias Lindbäck Ricardo Palanco Zamora others and contributes to ESTRO and AAPM educational programs. Her recent publications focus on heterogeneity handling , automated treatment plan validation , and prognostic modeling in brachytherapy. Key research themes include Model-based dose calculation algorithms Monte Carlo simulations Prostate and ocular tumor treatment optimization Clinical audits and calibration standards Machine learning for medical imaging with a strong emphasis on technical innovation and radiation safety in clinical settings.

Sila Çetinkayaمشاهده پروفایل

استاد

• Supply Chain Analytics
• Healthcare Operations
• Stochastic Optimal Control
• +۳ مورد دیگر

Dr. Sila Çetinkaya is the Cecil H. Green Professor of Engineering and Chair of the Operations Research and Engineering Management (OREM) department at Southern Methodist University’s Lyle School of Engineering. She also holds courtesy appointments in the ITOM department at the SMU Cox School of Business and in Internal Medicine at UT Southwestern Medical Center. Education: Ph.D. in Management Science, McMaster University, 1996 M.S. in Industrial Engineering, Bilkent University, 1991 B.S. in Industrial Engineering, Istanbul Technical University, 1989 Research Focus: Her research spans supply chain analytics , healthcare operations , stochastic optimal control , and applied probability . She investigates complex problems in inventory theory, distribution logistics, closed-loop supply chains, and coordination contracts. Publications & Impact: Her recent work emphasizes stochastic models for shipment consolidation, radiation therapy planning, and healthcare delivery for underserved populations. These studies are published in top-tier journals such as Operations Research , Management Science , and Transportation Research Part E . Awards & Honors: IISE Fellow (2012) CAREER Award, NSF (2001) Outstanding Young Industrial Engineer, IIE (2003) IISE Logistics and Supply Chain Division Teaching Award (2015) Moving Spirit Award, INFORMS (2011) Best Paper Prize, IISE Transactions (2010) Advising & Grants: She has mentored over 15 Ph.D. students and 30 master’s students. Her research has been funded by NSF, DOE, Texas Coordinating Board, Frito-Lay, Nokia, and others. She has led or co-led over 20 grants totaling millions in funding. Service & Leadership: She serves as Department Editor for IISE Transactions and Associate Editor for Naval Research Logistics . She has held leadership roles in INFORMS and IISE, including President of Women in OR/MS and Program Chair for INFORMS 2023.

Björn Morénمشاهده پروفایل

استادیار

• Mathematical Optimization
• Brachytherapy Treatment Planning
• Radiotherapy
• +۷ مورد دیگر

Björn Morén is an Assistant Professor in the Department of Mathematics at Linköping University, Sweden. He is affiliated with the Division of Applied Mathematics (TIMA), where his research focuses on mathematical optimization applied to brachytherapy treatment planning in radiation oncology. His work aims to improve cancer treatment outcomes through advanced computational models that enhance precision and robustness in radiotherapy. Research Interests: His primary research lies at the intersection of applied mathematics and medical physics. He specializes in developing and analyzing mathematical optimization models for high-dose-rate (HDR) brachytherapy, particularly for prostate and cervical cancers. His work addresses critical challenges such as rotational and positional uncertainties, dwell time optimization, and automated plan validation. He seeks to bridge the gap between manual clinical planning and algorithm-driven optimization to improve dosimetric outcomes and reduce complications. Publication Trends: His recent publications (2021–2025) demonstrate a consistent focus on robust optimization techniques in brachytherapy. Themes include uncertainty mitigation, dosimetric evaluation, inverse planning, and automation in treatment workflows. His interdisciplinary work combines operations research, medical imaging, and clinical oncology, reflecting strong collaboration across physics and medicine. Scientific Awards: No awards or honors are mentioned in the provided text. Advising and Grants: There is no information available about students advised or research grants received. However, his active publication record suggests ongoing funded research and potential mentorship roles within his research group. Labs and Teams: Björn Morén is part of a multidisciplinary research group at Linköping University focused on brachytherapy treatment planning. This group collaborates on developing optimization models for clinical use, working closely with medical physicists and oncologists to translate mathematical innovations into practical healthcare solutions.

• Cancer Imaging
• Genetic Risk Factors for Cancer
• Radiation Oncology
• +۳ مورد دیگر

Tyler Michael Seibert, MD, PhD, is a board-certified radiation oncologist affiliated with UC San Diego Health and the UC San Diego School of Medicine. He holds a medical degree from UC San Diego School of Medicine and a PhD in bioengineering from UC San Diego Jacobs School of Engineering. His clinical expertise includes intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic radiosurgery (SRS), and stereotactic body radiotherapy (SBRT) for cancers such as brain, prostate, and skin cancers. Dr. Seibert’s research focuses on cancer imaging and genetic risk factors for cancer. He completed residencies in radiation oncology and transitional medicine at UC San Diego School of Medicine and Scripps Mercy Hospital. He is an active member of the American Society for Radiation Oncology and the Radiological Society of North America. Professional affiliations include UC San Diego Moores Cancer Center. He joined UC San Diego Health in 2018 and is fluent in Spanish. Financial disclosures include research funding and general payments from pharmaceutical and medical device companies such as GE Healthcare, Telix Pharmaceuticals, and others, as reported in federal Open Payments data.

Lauren Boretaمشاهده پروفایل

استادیار

• Radiation Oncology
• Palliative Radiation Therapy
• Brain Metastases
• +۳ مورد دیگر

Dr. Lauren Boreta serves as an Assistant Professor in the Department of Radiation Oncology at the University of California, San Francisco (UCSF), where she leads the Palliative Radiation program, serves as Associate Director for Quality Assurance/Improvement, and acts as Assistant Residency Program Director. Her clinical expertise focuses on radiation for palliation of advanced cancer and treatment of central nervous system malignancies using stereotactic radiotherapy, radiosurgery, and intensity-modulated radiation therapy. Her educational journey includes a BA in Human Biology from Stanford University (2006), an MD from UCSF (2014), an Internal Medicine internship at Kaiser Permanente San Francisco (2015), and Radiation Oncology residency at UCSF (2015-2019) where she served as Chief Resident (2017-2018). Dr. Boreta's research centers on optimizing palliative radiation efficacy, addressing cancer-care disparities, and improving management of CNS metastases. She investigates stereotactic radiosurgery outcomes for brain metastases, particularly in breast cancer and melanoma, while exploring machine learning applications for predicting acute care needs and integrating multidisciplinary oncology rounding models for advanced cancer patients. Her recent publications demonstrate strong trends in brain metastases management, with emphasis on molecular profiling, spatial radiation targeting, and personalized therapy approaches. The work consistently addresses disparities in cancer care access and outcomes while advancing technical aspects of stereotactic radiation delivery. Dean’s Summer Research Fellowship (2011) Young Physician’s Award for Patient Safety – Lucian Leape Institute (2013) Alpha Omega Alpha Medical Honor Society (2014) As Assistant Residency Program Director and Chief Resident during training, Dr. Boreta actively contributes to medical education and quality improvement. Her leadership in the Palliative Radiation program focuses on optimizing symptom relief for advanced cancer patients through timely radiation interventions, while her quality assurance role enhances departmental clinical standards. Dr. Boreta co-founded the "Cancer Co-Rounds" multidisciplinary inpatient model integrating medical oncology, neuro-oncology, and radiation oncology for complex cancer cases, demonstrating her commitment to innovative team-based care for patients with advanced disease.

Alexandra Hotca-Choمشاهده پروفایل

استادیار

• Radiation Oncology
• Gastrointestinal Oncology
• Radiation Therapy Techniques
• +۳ مورد دیگر

Dr. Alexandra Hotca-Cho serves as an Assistant Professor in the Department of Radiation Oncology within the School of Medicine at the University of California, San Francisco (UCSF). Her clinical expertise centers on gastrointestinal cancers, where she employs advanced radiation modalities such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT), and respiratory gating to maximize tumor control while reducing adverse effects. Dr. Hotca-Cho is committed to patient advocacy and delivering compassionate, high-quality care to UCSF's diverse patient community. Her educational journey includes a Bachelor of Arts in Biology from Hunter College – CUNY (2014), followed by a Doctor of Medicine from Drexel University College of Medicine (2015-2019). She completed an Internal Medicine internship at Lenox Hill Hospital – Northwell Health (2019-2020) and a Radiation Oncology residency with a Chief Resident year at the Icahn School of Medicine at Mount Sinai (2020-2024). Dr. Hotca-Cho's research program is dedicated to improving cancer survivorship through two primary avenues: (1) developing preventive strategies to mitigate treatment-related toxicities, and (2) discovering predictive biomarkers that identify patients at risk for radiation-induced complications. Her scholarly work spans gastrointestinal oncology, precision radiation delivery, health equity, and quality-of-life outcomes. Recent publications demonstrate her leadership in hepatocellular carcinoma, esophageal cancer, and the application of proton therapy for recurrent malignancies. A review of her 15 most recent publications (2022-2024) highlights her focus on gastrointestinal malignancies and radiation toxicity management. Key themes include the safety of combined immunotherapy and radiation, predictive models for esophageal toxicity, and disparities in genomic testing and Medicaid coverage for cancer patients. Her work bridges clinical practice with translational research to enhance therapeutic precision. Her accolades include the Resident Clinical Excellence Award from Mount Sinai Hospital (2024) and the prestigious Luther W. Brady, MD Award from Drexel University College of Medicine (2019), recognizing her outstanding clinical performance and academic promise. While the source material does not specify current advisees or grant funding, Dr. Hotca-Cho's active research portfolio suggests ongoing mentorship of trainees and competitive research support. Similarly, no details about specific laboratories or research teams were provided, though her work likely involves multidisciplinary collaboration within UCSF's comprehensive cancer center.

• Medical Physics
• Radiation Oncology
• Proton Therapy
• +۵ مورد دیگر

Alexander Van Slyke serves as an Assistant Professor in the Department of Therapeutic Radiology at Yale School of Medicine, Yale University. His primary appointment focuses on medical physics research within the radiation oncology division, contributing to both clinical and preclinical radiation therapy advancements. His educational background includes: PhD in Biophysics from Cornell University (2019) BA in Physics and Mathematics from SUNY Geneseo (2012) Certificate in Medical Physics from University of Pennsylvania (2020) Medical Physics Residency at University of Maryland (2023) He holds board certification from the American Board of Radiology in Therapeutic Medical Physics (2024). Dr. Van Slyke's research centers on cutting-edge radiation therapy technologies and radiobiological mechanisms. His primary expertise spans FLASH radiotherapy (particularly proton FLASH), real-time electromagnetic surface tracking for motion management, oxygen dynamics monitoring during irradiation, and small animal radiation research. He employs advanced techniques like phosphorescence quenching for ultrafast oxygen sensing and develops optimization algorithms for treatment delivery. His work bridges medical physics innovation with radiobiological investigation to enhance radiation therapy precision. Analysis of his publications reveals a strong trajectory toward understanding ultra-high dose rate radiation effects, with recent work focusing on geometric validation of tracking systems (2025) and oxygen depletion dynamics during proton FLASH delivery. His research consistently integrates preclinical models with clinical translation, emphasizing motion management solutions and biological response characterization. Dr. Van Slyke actively contributes to departmental leadership as Acting Co-Chair of the C-RAD Optimization Committee and Chair of the Lung SBRT Planning Committee. His conference presentations at AAPM meetings demonstrate expertise in electromagnetic tracking feasibility, motion effect simulations for LATTICE therapy, and oxygen monitoring techniques. He operates within Yale's radiation oncology ecosystem, collaborating with medical physics and radiobiology teams to advance therapeutic radiology through technological innovation and radiobiological insight.